Riccio G - Search Results

1

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

Paciello R, Urbanowicz RA, Riccio G, Sasso E, McClure CP, Zambrano N, Ball JK, Cortese R, Nicosia A, De Lorenzo C. Paciello R, et al. Among authors: riccio g. J Gen Virol. 2016 Jan;97(1):82-94. doi: 10.1099/jgv.0.000330. Epub 2015 Oct 29. J Gen Virol. 2016. PMID: 26519290 Free PMC article.

2

One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1.

Sasso E, Paciello R, D'Auria F, Riccio G, Froechlich G, Cortese R, Nicosia A, De Lorenzo C, Zambrano N. Sasso E, et al. Among authors: riccio g. Biomed Res Int. 2015;2015:703213. doi: 10.1155/2015/703213. Epub 2015 Nov 15. Biomed Res Int. 2015. PMID: 26649313 Free PMC article.

3

A novel fully human antitumor immunoRNase resistant to the RNase inhibitor.

Riccio G, D'Avino C, Raines RT, De Lorenzo C. Riccio G, et al. Protein Eng Des Sel. 2013 Mar;26(3):243-8. doi: 10.1093/protein/gzs101. Epub 2012 Dec 11. Protein Eng Des Sel. 2013. PMID: 23232187 Free PMC article.

4

Effects of a human compact anti-ErbB2 antibody on gastric cancer.

Fedele C, Carvalho S, Riccio G, Paciello R, Laccetti P, Schmitt F, De Lorenzo C. Fedele C, et al. Among authors: riccio g. Gastric Cancer. 2014 Jan;17(1):107-15. doi: 10.1007/s10120-013-0244-z. Epub 2013 Mar 5. Gastric Cancer. 2014. PMID: 23460348

5

Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.

D'Avino C, Paciello R, Riccio G, Coppola C, Laccetti P, Maurea N, Raines RT, De Lorenzo C. D'Avino C, et al. Among authors: riccio g. Protein Eng Des Sel. 2014 Mar;27(3):83-8. doi: 10.1093/protein/gzt065. Epub 2014 Jan 12. Protein Eng Des Sel. 2014. PMID: 24421342 Free PMC article.

6

Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.

Fedele C, Riccio G, Malara AE, D'Alessio G, De Lorenzo C. Fedele C, et al. Among authors: riccio g. Breast Cancer Res Treat. 2012 Jul;134(2):595-602. doi: 10.1007/s10549-012-2103-8. Epub 2012 Jun 7. Breast Cancer Res Treat. 2012. PMID: 22674190

7

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine.

De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N. De Lorenzo C, et al. Among authors: riccio g. Onco Targets Ther. 2018 Apr 19;11:2241-2250. doi: 10.2147/OTT.S157294. eCollection 2018. Onco Targets Ther. 2018. PMID: 29719406 Free PMC article.

8

A novel human antitumor dimeric immunoRNase.

Riccio G, Borriello M, D'Alessio G, De Lorenzo C. Riccio G, et al. J Immunother. 2008 Jun;31(5):440-5. doi: 10.1097/CJI.0b013e31816bc769. J Immunother. 2008. PMID: 18463541

9

Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.

Fedele C, Riccio G, Coppola C, Barbieri A, Monti MG, Arra C, Tocchetti CG, D'Alessio G, Maurea N, De Lorenzo C. Fedele C, et al. Among authors: riccio g. Breast Cancer Res Treat. 2012 Jun;133(2):511-21. doi: 10.1007/s10549-011-1783-9. Epub 2011 Sep 27. Breast Cancer Res Treat. 2012. PMID: 21947749

10

T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells.

Riccio G, Ricardo AR, Passariello M, Saraiva K, Rubino V, Cunnah P, Mertens N, De Lorenzo C. Riccio G, et al. J Immunother. 2019 Jan;42(1):1-10. doi: 10.1097/CJI.0000000000000248. J Immunother. 2019. PMID: 30520849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page